10 patient support programs experts
Patient assistance, hub operations and patient services operations run through this patient support programs group: three people hold or held Director titles over patient assistance programs, at GSK, Takeda and AstraZeneca, and others oversee or oversaw hub, copay and reimbursement work at SUN PHARMA, Chiesi USA and Azurity Pharmaceuticals. Talk to them when choosing a hub vendor, setting assistance eligibility rules, or launching support for a new specialty product.
Professionals to explore
Christine McHenry
LinkedInExperience: Director, Patient Assistance Programs · AstraZeneca
$336 per 30-minute call
Helping patients afford their medications is the remit Christine McHenry describes as Director, Patient Assistance Programs at AstraZeneca since April 2011, responsible for strategy development and execution of programs for qualifying people without insurance. Christine's earlier AstraZeneca titles were Director, Contracting (2008–2011), Director, Strategic Initiatives & Institutions (2007–2008) and Director, Government Operations (2005–2007). Suited to questions on patient assistance strategy and eligibility.
Is this you? Claim your profile and get paid for calls.
Donna Walker
LinkedInExperience: Former Director, Patient Assistance Programs (PAP) · TAKEDA PHARMACEUTICALS AMERICA, INC.
$303 per 30-minute call
Donna Walker was Director, Patient Assistance Programs (PAP) at TAKEDA PHARMACEUTICALS AMERICA, INC. from August 2016 to March 2026, managing five PAPs for retail and specialty drugs, including new supplier implementations and new product launches. Donna was also Consultant, Commercial Operations and Patient Services at Evolve/FluidEdge Consulting (2014–2016) and Director Commercial Operations at Shire (2004–2014). Fits questions on switching assistance program suppliers and adding new products to a PAP.
Is this you? Claim your profile and get paid for calls.
Jacqueline Cronin
LinkedInExperience: Senior Patient Services & Support Programs Manager · Chiesi USA, Inc.
$169 per 30-minute call
In the Senior Patient Services & Support Programs Manager role at Chiesi USA, Inc. since January 2025, Jacqueline Cronin leads HUB, co-pay and patient assistance, prior authorization, non-commercial dispensing pharmacy, denial conversion and pharmacy sampling. Jacqueline was earlier Senior Manager, Marketing and Market Access at Avanos Medical (2021–2024), a Senior manager at ViiV Healthcare (2020–2021) and held senior marketing manager titles at Teleflex and Bioventus. The one for day-to-day questions on hub, copay and prior authorization work.
Is this you? Claim your profile and get paid for calls.
John Reid, MBA
LinkedInExperience: Director, Specialty & Oncology Patient Assistance Programs · GSK
$336 per 30-minute call
John Reid, MBA has been Director, Specialty & Oncology Patient Assistance Programs at GSK since December 2025, after Senior Director, Patient Services Operations at Teva Pharmaceuticals (2024–2025) and Vice President, Patient Support at Cycle Pharmaceuticals (2021–2023). John was also AD, Channel Accounts & Hub Strategy at Indivior (2017–2021) and AD, Patient Services Business Planning at Biogen (2005–2017), and describes work on patient access hub program operations, process definition and financial metrics. Fits questions on hub strategy and program metrics.
Is this you? Claim your profile and get paid for calls.
Katherine Lander
LinkedInExperience: Director, RLT Patient Support Program Strategy & Management · Novartis
$336 per 30-minute call
Katherine Lander has been Director, RLT Patient Support Program Strategy & Management at Novartis since January 2025. Katherine's other Novartis titles include Director, PSS Program Strategy & Design (Ligelizumab & Fabhalta) (2021–2023), Associate Director, Fabhalta Patient Support Center Team Manager (2023–2024) and a Kisqali patient support rotation (2024–2025), and Katherine was Director, Market Access Strategy Cardiopulmonary Hemophilia at Bayer (2020–2021). A fit for designing a support program alongside a product launch.
Is this you? Claim your profile and get paid for calls.
Michelle Capon
LinkedInExperience: National Director Patient Support Programs and Customer Service · GSK
$370 per 30-minute call
Michelle Capon holds three current GSK titles: National Director Patient Support Programs and Customer Service since July 2024, Director Patient Support Programs and Patient Access since May 2023 and National Patient Support Manager since October 2019. Michelle was also Director of Operations, Patient Support Services at Bayshore HealthCare (2017–2019) and has managed patient support implementations in Canada, the UK and the USA. Suited to questions on running patient support programs across countries.
Is this you? Claim your profile and get paid for calls.
Robin Tompkins
LinkedInExperience: Director, Patient Support Services and Ops · SUN PHARMA
$269 per 30-minute call
Robin Tompkins has been Director, Patient Support Services and Ops at SUN PHARMA since October 2021, overseeing hub operations for Sun Pharma's brand products portfolio, including biologics in Derm, Onc and Urol. Robin also held Assoc National Director, Field Reimbursement, Analytics and Training (2020–2022) and Assoc Dir, US Health Policy & Reimbursement (2018–2020) at SUN PHARMA, and was Business Relations Manager, Pat & Specialty Services, US Managed Markets at Novartis (2017–2018). A fit for hub operations and field reimbursement questions.
Is this you? Claim your profile and get paid for calls.
Sarah Derewitz
LinkedInExperience: Former Director, Patient Services Operations · bluebird bio
$269 per 30-minute call
Sarah Derewitz built, launched and refined a wraparound patient services support program as Director, Patient Services Operations at bluebird bio (2023–2025), and has held the same title at Intellia Therapeutics, Inc. since March 2026. At Horizon, Sarah was Associate Director, Patient Services Operations (2021–2023) and Patient Access Liaison (2018–2021), and earlier Patient Services Lead at Spark Therapeutics, Inc. (2016–2018). The pick for standing up a patient services program for a new therapy.
Is this you? Claim your profile and get paid for calls.
Tracey Walsh
LinkedInExperience: Former Head of U.S. Patient Support Services · Sanofi
$471 per 30-minute call
Tracey Walsh was Vice President Patient Services at Kiniksa Pharmaceuticals (2024–2025) and Head of U.S. Patient Support Services at Sanofi (2019–2024). Tracey held Associate Director (2015–2017), Director (2017–2018) and Sr. Director (2018–2019) titles in Patient Access Services at Alkermes, and describes designing patient service programs and distribution channels with teams across field and home office settings. Suits questions on field and home office team design for patient services.
Is this you? Claim your profile and get paid for calls.
Usha Roy, MBA
LinkedInExperience: Executive Director - Patient Support Services · MannKind Corporation
$336 per 30-minute call
Usha Roy, MBA has been Executive Director - Patient Support Services at MannKind Corporation since February 2026, after Senior Director, Patient Support and Reimbursement at Azurity Pharmaceuticals (2023–2026). Usha was also Director - Patient Services at Aimmune Therapeutics (2021–2023) and Vice President, Patient Services (Promoted 2X) at EVERSANA (2016–2020), with work spanning hubs, reimbursement, affordability programs, patient assistance and specialty pharmacy. Usha fits questions on hub, reimbursement and affordability program design for specialty and rare-disease portfolios.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Christine McHenry, Donna Walker and John Reid are the patient assistance program picks, with Donna Walker having managed five PAPs through supplier implementations and product launches. Robin Tompkins, Jacqueline Cronin and Usha Roy cover hub and copay operations; for a program built at launch, Sarah Derewitz and Katherine Lander have built or designed program strategy, while Michelle Capon holds and Tracey Walsh held national patient support titles.
Questions to take into the conversation
- 01When should a drug company keep its patient support hub in-house versus hire a hub vendor, and what should the contract measure?
- 02How should income and insurance eligibility rules be set for a patient assistance program so they hold up to compliance review?
- 03What does a patient support program need in place on launch day for a specialty product, from benefits checks to copay help?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.